Combined therapeutic use of umbilical cord blood serum and amniotic membrane in diabetic wounds
Diabetic wounds are hard-to-heal due to complex multifactorial dysregulation within the micro-environment, necessitating the development of novel regenerative approaches to stimulate healing. This study investigated whether the combined therapeutic application of two novel cellular tissue products,...
Gespeichert in:
Veröffentlicht in: | Biochimie 2024-12, Vol.227 (Pt A), p.193-204 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 204 |
---|---|
container_issue | Pt A |
container_start_page | 193 |
container_title | Biochimie |
container_volume | 227 |
creator | Montague, C. Holt, Y. Vlok, M. Dhanraj, P. Boodhoo, K. Maartens, M. Buthelezi, K. Niesler, C.U. van de Vyver, M. |
description | Diabetic wounds are hard-to-heal due to complex multifactorial dysregulation within the micro-environment, necessitating the development of novel regenerative approaches to stimulate healing. This study investigated whether the combined therapeutic application of two novel cellular tissue products, namely a decellularized collagen-rich amniotic membrane (AmR) and growth factor-rich umbilical cord blood serum (UCBS) could have a positive synergistic effect on long-term healing outcomes by stimulating both superficial wound closure and wound bed regeneration. Full thickness excisional wounds were induced on obese diabetic mice (B6.Cg-lepob/J, ob/ob, n = 23) and treated with either: 1) Standard wound care (control); 2) UCBS; 3) AmR or 4) UCBS + AmR. Macroscopic wound closure was assessed on days 0, 3, 7, 10 and 14 post wounding. To determine the potential impact on wound recurrence, endpoint analysis was performed to determine both the overall quality of healing histologically as well as the molecular state of the wounds on day 14 via proteomic analysis. The data demonstrated the presence of both healers and non-healers. Re-epithelization took place in the healers of all treatment groups, but underlying tissue regeneration was far more pronounced following application of the combined treatment (UCBS + AmR), suggesting improved quality of healing and potentially a reduced change of recurrence long term. In non-healers, wounds failed to heal due to excessive slough formation and a reduction in LTB4 expression, suggesting impaired antimicrobial activity. Care should thus be taken since the cellular tissue product therapy could pose an increased risk for infection in some patients.
•Combined use of amniotic membrane and UCBS can promote regeneration of diabetic wounds.•Umbilical cord blood serum contains growth factors and chemokines in abundance.•Cellular tissue product therapy could pose an increased risk for infection.•In non-healers excessive slough formation coincided with a reduction in LTB4 expression. |
doi_str_mv | 10.1016/j.biochi.2024.07.012 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3084029265</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0300908424001718</els_id><sourcerecordid>3084029265</sourcerecordid><originalsourceid>FETCH-LOGICAL-c241t-4878f4f3d4a9b8ca25b127b460c258286af97f9fe607eb7c56f0b565b28696533</originalsourceid><addsrcrecordid>eNp9kEtv1DAQgC1ERbdb_gFCPnJJGD_iJBcktCpQqRKX9mz5MVa9SuLFTkD8e7zawpHTSDPfvD5C3jFoGTD18djamNxzbDlw2ULfAuOvyI4pMTSKDeI12YEAaEYY5DW5KeUIAB3w8Q25FiNIIbphR_QhzTYu6On6jNmccFujo1tBmgLdammKzkzUpeypnVLytGDeZmoWT828xHTGZ5xtNgvSuFAfjcVz8lfaFl9uyVUwU8G3L3FPnr7cPR6-NQ_fv94fPj80jku2NnLohyCD8NKMdnCGd5bx3koFjncDH5QJYx_GgAp6tL3rVADbqc7W0qg6Ifbkw2XuKacfG5ZVz7E4nKZ6VtqKFtVC_Z1Xdk_kBXU5lZIx6FOOs8m_NQN9VquP-qJWn9Vq6HVVW9vev2zY7Iz-X9NflxX4dAGw_vkzYtbFRVwc-pjRrdqn-P8NfwAjB4wq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3084029265</pqid></control><display><type>article</type><title>Combined therapeutic use of umbilical cord blood serum and amniotic membrane in diabetic wounds</title><source>Elsevier ScienceDirect Journals Complete - AutoHoldings</source><source>MEDLINE</source><creator>Montague, C. ; Holt, Y. ; Vlok, M. ; Dhanraj, P. ; Boodhoo, K. ; Maartens, M. ; Buthelezi, K. ; Niesler, C.U. ; van de Vyver, M.</creator><creatorcontrib>Montague, C. ; Holt, Y. ; Vlok, M. ; Dhanraj, P. ; Boodhoo, K. ; Maartens, M. ; Buthelezi, K. ; Niesler, C.U. ; van de Vyver, M.</creatorcontrib><description>Diabetic wounds are hard-to-heal due to complex multifactorial dysregulation within the micro-environment, necessitating the development of novel regenerative approaches to stimulate healing. This study investigated whether the combined therapeutic application of two novel cellular tissue products, namely a decellularized collagen-rich amniotic membrane (AmR) and growth factor-rich umbilical cord blood serum (UCBS) could have a positive synergistic effect on long-term healing outcomes by stimulating both superficial wound closure and wound bed regeneration. Full thickness excisional wounds were induced on obese diabetic mice (B6.Cg-lepob/J, ob/ob, n = 23) and treated with either: 1) Standard wound care (control); 2) UCBS; 3) AmR or 4) UCBS + AmR. Macroscopic wound closure was assessed on days 0, 3, 7, 10 and 14 post wounding. To determine the potential impact on wound recurrence, endpoint analysis was performed to determine both the overall quality of healing histologically as well as the molecular state of the wounds on day 14 via proteomic analysis. The data demonstrated the presence of both healers and non-healers. Re-epithelization took place in the healers of all treatment groups, but underlying tissue regeneration was far more pronounced following application of the combined treatment (UCBS + AmR), suggesting improved quality of healing and potentially a reduced change of recurrence long term. In non-healers, wounds failed to heal due to excessive slough formation and a reduction in LTB4 expression, suggesting impaired antimicrobial activity. Care should thus be taken since the cellular tissue product therapy could pose an increased risk for infection in some patients.
•Combined use of amniotic membrane and UCBS can promote regeneration of diabetic wounds.•Umbilical cord blood serum contains growth factors and chemokines in abundance.•Cellular tissue product therapy could pose an increased risk for infection.•In non-healers excessive slough formation coincided with a reduction in LTB4 expression.</description><identifier>ISSN: 0300-9084</identifier><identifier>ISSN: 1638-6183</identifier><identifier>EISSN: 1638-6183</identifier><identifier>DOI: 10.1016/j.biochi.2024.07.012</identifier><identifier>PMID: 39043358</identifier><language>eng</language><publisher>France: Elsevier B.V</publisher><subject>Amnion ; Amniotic membrane ; Animals ; Diabetes ; Diabetes Mellitus, Experimental - therapy ; Female ; Fetal Blood - cytology ; Humans ; Leukotriene B4 ; Male ; Mice ; Umbilical cord blood serum ; Wound Healing</subject><ispartof>Biochimie, 2024-12, Vol.227 (Pt A), p.193-204</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c241t-4878f4f3d4a9b8ca25b127b460c258286af97f9fe607eb7c56f0b565b28696533</cites><orcidid>0000-0002-0861-2939</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.biochi.2024.07.012$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39043358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Montague, C.</creatorcontrib><creatorcontrib>Holt, Y.</creatorcontrib><creatorcontrib>Vlok, M.</creatorcontrib><creatorcontrib>Dhanraj, P.</creatorcontrib><creatorcontrib>Boodhoo, K.</creatorcontrib><creatorcontrib>Maartens, M.</creatorcontrib><creatorcontrib>Buthelezi, K.</creatorcontrib><creatorcontrib>Niesler, C.U.</creatorcontrib><creatorcontrib>van de Vyver, M.</creatorcontrib><title>Combined therapeutic use of umbilical cord blood serum and amniotic membrane in diabetic wounds</title><title>Biochimie</title><addtitle>Biochimie</addtitle><description>Diabetic wounds are hard-to-heal due to complex multifactorial dysregulation within the micro-environment, necessitating the development of novel regenerative approaches to stimulate healing. This study investigated whether the combined therapeutic application of two novel cellular tissue products, namely a decellularized collagen-rich amniotic membrane (AmR) and growth factor-rich umbilical cord blood serum (UCBS) could have a positive synergistic effect on long-term healing outcomes by stimulating both superficial wound closure and wound bed regeneration. Full thickness excisional wounds were induced on obese diabetic mice (B6.Cg-lepob/J, ob/ob, n = 23) and treated with either: 1) Standard wound care (control); 2) UCBS; 3) AmR or 4) UCBS + AmR. Macroscopic wound closure was assessed on days 0, 3, 7, 10 and 14 post wounding. To determine the potential impact on wound recurrence, endpoint analysis was performed to determine both the overall quality of healing histologically as well as the molecular state of the wounds on day 14 via proteomic analysis. The data demonstrated the presence of both healers and non-healers. Re-epithelization took place in the healers of all treatment groups, but underlying tissue regeneration was far more pronounced following application of the combined treatment (UCBS + AmR), suggesting improved quality of healing and potentially a reduced change of recurrence long term. In non-healers, wounds failed to heal due to excessive slough formation and a reduction in LTB4 expression, suggesting impaired antimicrobial activity. Care should thus be taken since the cellular tissue product therapy could pose an increased risk for infection in some patients.
•Combined use of amniotic membrane and UCBS can promote regeneration of diabetic wounds.•Umbilical cord blood serum contains growth factors and chemokines in abundance.•Cellular tissue product therapy could pose an increased risk for infection.•In non-healers excessive slough formation coincided with a reduction in LTB4 expression.</description><subject>Amnion</subject><subject>Amniotic membrane</subject><subject>Animals</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Experimental - therapy</subject><subject>Female</subject><subject>Fetal Blood - cytology</subject><subject>Humans</subject><subject>Leukotriene B4</subject><subject>Male</subject><subject>Mice</subject><subject>Umbilical cord blood serum</subject><subject>Wound Healing</subject><issn>0300-9084</issn><issn>1638-6183</issn><issn>1638-6183</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtv1DAQgC1ERbdb_gFCPnJJGD_iJBcktCpQqRKX9mz5MVa9SuLFTkD8e7zawpHTSDPfvD5C3jFoGTD18djamNxzbDlw2ULfAuOvyI4pMTSKDeI12YEAaEYY5DW5KeUIAB3w8Q25FiNIIbphR_QhzTYu6On6jNmccFujo1tBmgLdammKzkzUpeypnVLytGDeZmoWT828xHTGZ5xtNgvSuFAfjcVz8lfaFl9uyVUwU8G3L3FPnr7cPR6-NQ_fv94fPj80jku2NnLohyCD8NKMdnCGd5bx3koFjncDH5QJYx_GgAp6tL3rVADbqc7W0qg6Ifbkw2XuKacfG5ZVz7E4nKZ6VtqKFtVC_Z1Xdk_kBXU5lZIx6FOOs8m_NQN9VquP-qJWn9Vq6HVVW9vev2zY7Iz-X9NflxX4dAGw_vkzYtbFRVwc-pjRrdqn-P8NfwAjB4wq</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Montague, C.</creator><creator>Holt, Y.</creator><creator>Vlok, M.</creator><creator>Dhanraj, P.</creator><creator>Boodhoo, K.</creator><creator>Maartens, M.</creator><creator>Buthelezi, K.</creator><creator>Niesler, C.U.</creator><creator>van de Vyver, M.</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0861-2939</orcidid></search><sort><creationdate>202412</creationdate><title>Combined therapeutic use of umbilical cord blood serum and amniotic membrane in diabetic wounds</title><author>Montague, C. ; Holt, Y. ; Vlok, M. ; Dhanraj, P. ; Boodhoo, K. ; Maartens, M. ; Buthelezi, K. ; Niesler, C.U. ; van de Vyver, M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c241t-4878f4f3d4a9b8ca25b127b460c258286af97f9fe607eb7c56f0b565b28696533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amnion</topic><topic>Amniotic membrane</topic><topic>Animals</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Experimental - therapy</topic><topic>Female</topic><topic>Fetal Blood - cytology</topic><topic>Humans</topic><topic>Leukotriene B4</topic><topic>Male</topic><topic>Mice</topic><topic>Umbilical cord blood serum</topic><topic>Wound Healing</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Montague, C.</creatorcontrib><creatorcontrib>Holt, Y.</creatorcontrib><creatorcontrib>Vlok, M.</creatorcontrib><creatorcontrib>Dhanraj, P.</creatorcontrib><creatorcontrib>Boodhoo, K.</creatorcontrib><creatorcontrib>Maartens, M.</creatorcontrib><creatorcontrib>Buthelezi, K.</creatorcontrib><creatorcontrib>Niesler, C.U.</creatorcontrib><creatorcontrib>van de Vyver, M.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Biochimie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Montague, C.</au><au>Holt, Y.</au><au>Vlok, M.</au><au>Dhanraj, P.</au><au>Boodhoo, K.</au><au>Maartens, M.</au><au>Buthelezi, K.</au><au>Niesler, C.U.</au><au>van de Vyver, M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined therapeutic use of umbilical cord blood serum and amniotic membrane in diabetic wounds</atitle><jtitle>Biochimie</jtitle><addtitle>Biochimie</addtitle><date>2024-12</date><risdate>2024</risdate><volume>227</volume><issue>Pt A</issue><spage>193</spage><epage>204</epage><pages>193-204</pages><issn>0300-9084</issn><issn>1638-6183</issn><eissn>1638-6183</eissn><abstract>Diabetic wounds are hard-to-heal due to complex multifactorial dysregulation within the micro-environment, necessitating the development of novel regenerative approaches to stimulate healing. This study investigated whether the combined therapeutic application of two novel cellular tissue products, namely a decellularized collagen-rich amniotic membrane (AmR) and growth factor-rich umbilical cord blood serum (UCBS) could have a positive synergistic effect on long-term healing outcomes by stimulating both superficial wound closure and wound bed regeneration. Full thickness excisional wounds were induced on obese diabetic mice (B6.Cg-lepob/J, ob/ob, n = 23) and treated with either: 1) Standard wound care (control); 2) UCBS; 3) AmR or 4) UCBS + AmR. Macroscopic wound closure was assessed on days 0, 3, 7, 10 and 14 post wounding. To determine the potential impact on wound recurrence, endpoint analysis was performed to determine both the overall quality of healing histologically as well as the molecular state of the wounds on day 14 via proteomic analysis. The data demonstrated the presence of both healers and non-healers. Re-epithelization took place in the healers of all treatment groups, but underlying tissue regeneration was far more pronounced following application of the combined treatment (UCBS + AmR), suggesting improved quality of healing and potentially a reduced change of recurrence long term. In non-healers, wounds failed to heal due to excessive slough formation and a reduction in LTB4 expression, suggesting impaired antimicrobial activity. Care should thus be taken since the cellular tissue product therapy could pose an increased risk for infection in some patients.
•Combined use of amniotic membrane and UCBS can promote regeneration of diabetic wounds.•Umbilical cord blood serum contains growth factors and chemokines in abundance.•Cellular tissue product therapy could pose an increased risk for infection.•In non-healers excessive slough formation coincided with a reduction in LTB4 expression.</abstract><cop>France</cop><pub>Elsevier B.V</pub><pmid>39043358</pmid><doi>10.1016/j.biochi.2024.07.012</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0861-2939</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0300-9084 |
ispartof | Biochimie, 2024-12, Vol.227 (Pt A), p.193-204 |
issn | 0300-9084 1638-6183 1638-6183 |
language | eng |
recordid | cdi_proquest_miscellaneous_3084029265 |
source | Elsevier ScienceDirect Journals Complete - AutoHoldings; MEDLINE |
subjects | Amnion Amniotic membrane Animals Diabetes Diabetes Mellitus, Experimental - therapy Female Fetal Blood - cytology Humans Leukotriene B4 Male Mice Umbilical cord blood serum Wound Healing |
title | Combined therapeutic use of umbilical cord blood serum and amniotic membrane in diabetic wounds |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A09%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20therapeutic%20use%20of%20umbilical%20cord%20blood%20serum%20and%20amniotic%20membrane%20in%20diabetic%20wounds&rft.jtitle=Biochimie&rft.au=Montague,%20C.&rft.date=2024-12&rft.volume=227&rft.issue=Pt%20A&rft.spage=193&rft.epage=204&rft.pages=193-204&rft.issn=0300-9084&rft.eissn=1638-6183&rft_id=info:doi/10.1016/j.biochi.2024.07.012&rft_dat=%3Cproquest_cross%3E3084029265%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3084029265&rft_id=info:pmid/39043358&rft_els_id=S0300908424001718&rfr_iscdi=true |